Medical Research Institute
Medical Research Institute
Alexandria, Bab Sharqi, Egypt1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, doxorubicin induced cardiomyopathy, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-04-17 | NCT06427226 |